Analysts meticulously research for up to 3-4 months to put together one suite of reports, a MedSuite, which is a comprehensive analysis of a group of healthcare markets. This MedCore is one portion of that analysis that focuses on the Intrathecal Pumps market segment and provides detailed analysis on the Market Size, Unit Sales, ASPs, and Company Market Shares.
Intrathecal Pumps Market Insights
The market value for intrathecal pumps is heavily dependent on Medtronic’s performance as the market leader in this space. The market for this device was slightly impacted in 2017, as Medtronic’s Synchromed® II was issued a Class 1 recall at the end of 2016 to address a software issue that can result in the unintended delivery of medication. Though this recall remained open at the time of publication, Medtronic was able to mostly make up for losses in this market in 2018, with the FDA approval of an innovative clinician programmer.
Intrathecal Pumps Market Insights
The market value for intrathecal pumps is heavily dependent on Medtronic’s performance as the market leader in this space. The market for this device was slightly impacted in 2017, as Medtronic’s Synchromed® II was issued a Class 1 recall at the end of 2016 to address a software issue that can result in the unintended delivery of medication. Though this recall remained open at the time of publication, Medtronic was able to mostly make up for losses in this market in 2018, with the FDA approval of an innovative clinician programmer.
